Oramed Pharmaceuticals
ORMP
ORMP
26 hedge funds and large institutions have $2.94M invested in Oramed Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
1.35% less ownership
Funds ownership: 6.18% → 4.83% (-1.3%)
23% less capital invested
Capital invested by funds: $3.83M → $2.94M (-$894K)
Holders
26
Holding in Top 10
1
Calls
$30K
Puts
$1K
Top Buyers
| 1 | +$191K | |
| 2 | +$155K | |
| 3 | +$60K | |
| 4 |
BlackRock
New York
|
+$8.71K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$6K |
Top Sellers
| 1 | -$1.17M | |
| 2 | -$38K | |
| 3 | -$35.6K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$19.1K |
| 5 |
SWM
SeaCrest Wealth Management
Purchase,
New York
|
-$5K |